Home

Kaye I Foster-Cheek

CIK 1312622 · SVP, Global Human Resources · last filed 2026-06-23

Kaye I Foster-Cheek is a SVP, Global Human Resources who has filed 69 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for AGIO, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$16.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions. 27 SEC filings were submitted jointly with & JOHNSON JOHNSON.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.65M

Companies

4

Total Filings

69

Lifetime Open-Market Net

-$16.38M

Filer Profile

Reported Address
C/O AGIOS PHARMACEUTICALS, INC.
88 SIDNEY STREET
CAMBRIDGE, MA 02139
Related Filers
& JOHNSON JOHNSON — 27 joint filings, latest 2010-01-05
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGIO Director 12,484 $33.60 $419.5K -$2.24M 24 2026-06-23
PRME Director — $3.13 — $0 6 2026-06-08
ONYX PHARMACEUTICALS INC (ONXX) Delisted SVP, Global Human Resources 33,556 — — -$7.88M 15 2013-08-08
JNJ VP, Human Resources 4,616 $265.58 $1.23M -$6.27M 20 2010-01-05

Recent Filings

69 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-23 AGIO Mixed +2,816 $0 EDGAR
2026-06-08 PRME Grant (A) — $0 EDGAR
2025-08-05 PRME Mixed — $0 EDGAR
2025-06-23 AGIO Mixed +2,120 $0 EDGAR
2025-06-05 PRME Grant (A) — $0 EDGAR
2024-06-24 AGIO Grant (A) — $0 EDGAR
2024-06-17 AGIO Mixed −176 $0 EDGAR
2024-06-14 PRME Grant (A) — $0 EDGAR
2024-03-11 AGIO Sell (S) −1,285 -$40.6K EDGAR
2024-03-07 AGIO Notice (144) −1,285 -$40.6K EDGAR
Showing 1–10 of 69
Page 1 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.